Luigi Naldini, Professor

Director, San Raffaele-Telethon Institute for Gene Therapy (TIGET) & Division of Regenerative Medicine, Stem Cells & Gene Therapy, San Raffaele Scientific Institute

Professor of “Cell and Tissue Biology” and “Cell and Gene Therapy”, “Vita-Salute San Raffaele” University School of Medicine

Past President of the European Society of Gene and Cell Therapy (ESGCT; 2012-2014)

Member of Board of Directors (2005-08) and Advisory Council of the American Society of Gene and Cell Therapy (ASGCT; 2008-12 )

Author of >250 scientific publications, cumulative IF >2.089 (avg. IF 10.93), h-index 84, >32.700 citations

Inventor of 58 granted and 45 pending patents

Scientific Advisor on EMEA and WHO Committees for the evaluation of novel gene transfer medicines

Awarded the European Research Council (ERC) Advanced Investigator Grant: top EU scientist, 2009

Outstanding Investigator Award from ASGCT in 2014 and from ESGCT in 2015